Institute for Health Metrics and Evaluation (IHME)

02/14/2026

In 2023, cardiovascular diseases (CVDs) were the leading cause of disability-adjusted life years, or DALYs—an indicator for the loss of healthy life.

CVDs were responsible for 437 million DALYs, and the leading cardiovascular causes of DALYs were ischemic heart disease, intracerebral hemorrhage, ischemic stroke, and hypertensive heart disease. Age-standardized DALYs were greater for men compared to women.

Read the comprehensive study, published in JACC Journals → http://ms.spr.ly/6185QRbOd

02/13/2026

We recently spoke with Dr. Catherine Johnson, Lead Research Scientist at IHME, who co-authored new research published in JAMA that uncovered major findings: adult obesity in the US has more than doubled in the past three decades and 47% of adults are projected to have obesity by 2035.

Watch the full Q&A video → http://ms.spr.ly/6188QRTI0

02/12/2026

Cancer was estimated to be the second leading cause of death globally in 2023. Cancer deaths are expected to rise to over 18 million in 2050, according to research published in The Lancet.

Using Global Burden of Disease (GBD) 2023 study results, authors analyzed estimates of cancer burden for 47 cancer types (excluding non-melanoma skin cancer) for 204 countries and territories from 1990 to 2023 with forecasts to 2050.

Read the study: http://ms.spr.ly/6184sS5qI

02/11/2026

IHME’s Roux Prize recipients have been steadfast in their pursuit of health equity through ongoing contributions and commitment to change. Nominations for the 2026 Roux Prize are now open until April 3!

◦ Dr. Adekemi Adeniyan (2025 recipient) works to expand access to dental care in rural Nigeria.

◦ Dr. Madeleine Ballard and the Community Health Impact Coalition (2024 recipients) provide health care through a global network of Community Health Workers.

◦ Dr. Ibrahim Abubakar (2023 recipient) used evidence-based research that led directly to Nigeria passing a new law mandating basic health insurance and the creation of a fund for vulnerable populations that covers 83 million people.

Do you know an individual or organization who is using health evidence in creative ways to better their communities? Submit a nomination by April 3, 2026: http://ms.spr.ly/6186QuYkg

Learn more about the Roux Prize: http://ms.spr.ly/6187QuYk9

02/10/2026

Women in the US are experiencing the highest burdens of obesity. In 2022, the highest levels were seen among non-Hispanic Black women (56.9%) and Hispanic women (49.4%).

Among men, the highest levels were also in these groups: non-Hispanic Black men (40.4%) and Hispanic men (42.6%). Read the new research published in JAMA that examined state-level prevalence of adult obesity by race and ethnicity: http://ms.spr.ly/6187QPJ8X

02/09/2026

The NUS Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and IHME recently hosted a regional forum in conjunction with the launch of the new NUS-IHME Global Burden of Disease Research Centre.

Global health leaders convened to focus on challenges facing populations in Southeast Asia: disease burden associated with aging and policies to enhance longevity, the health impacts of climate change, and the threat of antimicrobial resistance.

Health officials and academics collaborated on key areas: Global Burden of Disease fundamentals, policy application, and data system strengthening for the region.

• Learn more about the regional forum: http://ms.spr.ly/6187QPyDc
• Learn more about the launch of the NUS-IHME Global Burden of Disease Research Centre: http://ms.spr.ly/6188QPyDY

02/06/2026

Smoking was the leading contributor to poor respiratory health outcomes across Asia, according to research published in The Lancet Respiratory Medicine using Global Burden of Disease 2023 study data to estimate the burden of chronic respiratory disease (CRD).

Smoking contributed most to CRD impact among men, while ambient and household air pollution and secondhand smoke were major contributors among women, particularly in South and Southeast Asia.

• Read the research: http://ms.spr.ly/6187Q3Mlb

02/05/2026

Adult obesity in the United States has more than doubled over the past three decades, rising from 19% of adults in 1990 to more than 42% in 2022, according to new research published in JAMA.

The analysis also forecasts obesity to continue increasing nationwide, reaching an estimated 47% of adults by 2035: http://ms.spr.ly/6188QMw3r

02/02/2026

02/02/2026

We’re excited to announce the launch of the NUS-IHME Global Burden of Disease Research Centre, a new regional hub to tackle aging, climate, and chronic disease risks across Southeast Asia.

Yong Loo Lin School of Medicine at National University of Singapore and IHME are working together to deliver scientific evidence that leaders can translate into policy. The Centre will host a policy forum with key experts to strengthen the region’s capacity for high-level health analysis, policy translation, and practical applications.

Learn more about the launch of the NUS-IHME Global Burden of Disease Research Centre: http://ms.spr.ly/6189QKEb1 and the upcoming policy forum: http://ms.spr.ly/6182QKEby.

01/29/2026

Addressing the prevalence of noncommunicable diseases, or NCDs (namely obesity, hypertension, cardiovascular disease, and diabetes), can help bolster future pandemic preparedness, according to IHME research presented in a recent piece from Think Global Health: http://ms.spr.ly/6184QHXt0

01/27/2026

New research studied the burden of chronic respiratory disease (CRD) across 34 countries in Asia from 1990 to 2023 and found CRD prevalence was broadly similar across nations despite income levels and health system capacity.

Asthma was most common in high-income Asia Pacific and Southeast Asia, while South Asia continues to experience the highest health loss, especially from chronic obstructive pulmonary disease.

Explore trends of CRD across Asia in the research published in The Lancet Respiratory Medicine: http://ms.spr.ly/6183Q1QwS